Rare ER protein misfolding-mistrafficking disorders: Therapeutic developments

Ramanath Narayana Hegde, Advait Subramanian, Prathyush Pothukuchi, Seetharaman Parashuraman, Alberto Luini

Research output: Contribution to journalReview articlepeer-review


The presence of a functional protein at the appropriate location in the cell is the result of the processes of transcription, translation, folding and trafficking to the correct destination. There are numerous diseases that are caused by protein misfolding, mainly due to mutations in the respective gene. The consequences of this misfolding may be that proteins effectively lose their function, either by being removed by the cellular quality control machinery or by accumulating at the incorrect intracellular or extracellular location. A number of mutations that lead to protein misfolding and affect trafficking to the final destination, e.g. Cystic fibrosis, Wilson's disease, and Progressive Familial Intrahepatic 1 cholestasis, result in proteins that retain partial function if their folding and trafficking is restored either by molecular or pharmacological means. In this review, we discuss several mutant proteins within this class of misfolding diseases and provide an update on the status of molecular and therapeutic developments and potential therapeutic strategies being developed to counter these diseases.

Original languageEnglish
Pages (from-to)175-185
Number of pages11
JournalTissue and Cell
Issue number2
Publication statusPublished - Apr 1 2017


  • ERAD
  • Misfolding
  • Mutations
  • Trafficking

ASJC Scopus subject areas

  • Developmental Biology
  • Cell Biology


Dive into the research topics of 'Rare ER protein misfolding-mistrafficking disorders: Therapeutic developments'. Together they form a unique fingerprint.

Cite this